Patents by Inventor Folke Morén

Folke Morén has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Formulation and use thereof
    Patent number: 8642627
    Abstract: Provided are liquid pharmaceutical formulations comprising nicotine in any form for administration essentially to the lungs being acidified and/or alkalized by buffering and/or pH regulation providing for a tmax of nicotine in arterial blood of a subject within a short period of time after administration. The administration is preferably accomplished by spraying an aerosol into the oral cavity for further distribution essentially into the lungs. Methods for manufacturing the formulation is also disclosed, as are uses of the formulation in therapy, such as therapy for treating addiction to tobacco.
    Type: Grant
    Filed: June 18, 2010
    Date of Patent: February 4, 2014
    Assignee: McNeil AB
    Inventors: Mark P. Warchol, Folke Moren, Kristina Thyresson, Elisabeth Sthengel, Sven-Borje Andersson
  • New Formulation and Use Thereof
    Publication number: 20100260688
    Abstract: Provided are liquid pharmaceutical formulations comprising nicotine in any form for administration essentially to the lungs being acidified and/or alkalized by buffering and/or pH regulation providing for a tmax of nicotine in arterial blood of a subject within a short period of time after administration. The administration is preferably accomplished by spraying an aerosol into the oral cavity for further distribution essentially into the lungs. Methods for manufacturing the formulation is also disclosed, as are uses of the formulation in therapy, such as therapy for treating addiction to tobacco.
    Type: Application
    Filed: June 18, 2010
    Publication date: October 14, 2010
    Inventors: Mark P. Warchol, Folke Morén, Kristina Thyresson, Elisabeth Sthengel, Sven-Börje Andersson
  • Formulation and use thereof
    Patent number: 7767698
    Abstract: A liquid pharmaceutical formulation comprising nicotine in any form for administration essentially to the lungs being acidified and/or alkalized by buffering and/or pH regulation providing for a tmax of nicotine in arterial blood of a subject within a short period of time after administration. The administration is preferably by spraying an aerosol into the oral cavity for further distribution essentially into the lungs. A method for manufacturing said formulation. Use of said formulation in therapy, such as therapy for treating addiction to tobacco.
    Type: Grant
    Filed: June 2, 2003
    Date of Patent: August 3, 2010
    Assignee: McNeil AB
    Inventors: Mark P. Warchol, Folke Morén, Kristina Thyresson, Elisabeth Sthengel, Sven-Börje Andersson
  • New formulation and use thereof
    Publication number: 20040034068
    Abstract: A liquid pharmaceutical formulation comprising nicotine in any form for administration essentially to the lungs being acidified and/or alkalized by buffering and/or pH regulation providing for a tmax of nicotine in arterial blood of a subject within a short period of time after administration.
    Type: Application
    Filed: June 2, 2003
    Publication date: February 19, 2004
    Applicant: WOODCOCK WASHBURN LLP
    Inventors: Mark P. Warchol, Folke Moren, Kristina Thyresson, Elisabeth Sthengel, Sven-Borje Andersson